Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells

International Journal of Urology

Volumn 9, Issue 10, 2002, Pages 577-585

  Miyagi, T ^a   Hori, O ^a   Koshida, K ^a   Egawa, M ^a   Kato, H ^a   Kitagawa, Y ^a   Ozawa, K ^a   Ogawa, S ^a   Namiki, M ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Antisense; Gene therapy; Molecular chaperone; Prostate cancer

Indexed keywords

ADENOVIRUS VECTOR; CHAPERONE; COMPLEMENTARY DNA; FLUORESCEIN ISOTHIOCYANATE; HEAT SHOCK PROTEIN; PROTEIN ORP150; RECOMBINANT DNA; UNCLASSIFIED DRUG; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; OXYGEN REGULATED PROTEINS; OXYGEN-REGULATED PROTEINS; PROTEIN; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CARCINOGENESIS; CARCINOGENICITY; CHORIOALLANTOIS; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING; XENOGRAFT; ANIMAL; ANIMAL MODEL; CELL CULTURE; CELL TRANSFORMATION; DRUG EFFECT; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; MALE; METHODOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROSTATE TUMOR; VASCULARIZATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA, ANTISENSE; ENDOTHELIAL GROWTH FACTORS; GENE THERAPY; GENETIC VECTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MICE; MICE, NUDE; MODELS, ANIMAL; MOLECULAR CHAPERONES; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; PROTEINS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036433660     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00519.x     Document Type: Article

References (17)

1. Kuwabara K, Matsumoto M, Ikeda J et al. Purification and characterization of a novel stress protein, the 150-kDa oxygen-regulated protein (ORP150), from cultured rat astrocytes and its expression in ischemic mouse brain. J. Biol. Chem. 1996; 279: 5025-32.
2. Ikeda J, Kaneda S, Kuwabara K et al. Cloning and expression of cDNA encoding the human 150 kDa oxygen-regulated protein, ORP150. Biochem. Biophys. Res. Commun. 1997; 230: 94-9.
3. Matsushita K, Matsuyama T, Nishimura H et al. Marked, sustained expression of a novel 150-kDa oxygen-regulated stress protein, in severely ischemic mouse neurons. Brain Res. Mol. Brain Res. 1998; 60: 98-106.
4. Ozawa K, Kuwabara K, Tamatani M et al. 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J. Biol. Chem. 1999; 274: 6397-404.
5. Tsukamoto Y, Kuwabara K, Hirota S et al. Expression of the 150-kd oxygen-regulated protein in human breast cancer. Lab. Invest. 1998; 78: 699-706.
6. Ozawa K, Tsukamoto Y, Hori O et al. Regulation of tumor angiogenesis by ORP150, an inducible endoplasmic reticulum chaperone. Cancer Res. 2001; 61: 4206-13.
7. Miyake S, Makimura M, Kanegae Y et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl Acad. Sci. USA, 1996; 93: 1320-4.
8. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid and guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem. 1987; 162: 156.
9. Boshoff C, Endo Y, Collins PD et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science, 1997; 278: 290-4.
10. Uchibayashi T, Egawa M, Nakajima K et al. Responses of tumour cell lines implanted onto the chorioallantoic membrane of chick embryo to anticancer agents in combination with hyperthermia. Urol. Res. 1992; 20: 237-9.
11. Garrido C, Fromentin A, Bonnotte B et al. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res. 1998; 58: 5495-9.
12. Bubendorf L, Kolmer M, Kononen J et al. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays. J. Natl Cancer. Inst. 1999; 91: 1758-64.
13. Kaur J, Ralhan R. Differential expression of 70-kDa heat shock protein in human oral tumorigenesis. Int. J. Cancer 1995; 63: 774-9.
14. Lazaris AC, Chatzigianni EB, Panoussopoulos D, Tzimas GN, Davaris PS, Golematis BC. Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res. Treat. 1997; 43: 43-51.
15. Kaur J, Srivastava A, Ralhan R. Expression of 70-kDa heat shock protein in oral lesions: Marker of biological stress or pathogenicity. Eur. J. Cancer B Oral Oncol. 1998; 34: 496-501.
16. Koong AC, Chen EY, Lee AS, Brown JM, Giaccia AJ. Increased cytotoxicity of chronic hypoxic cells by molecular inhibition of GRP78 induction. Int. J. Radiat. Oncol. Biol. Phys. 1994; 28: 661-6.
17. Kaur J, Kaur J, Ralhan R. Induction of apoptosis by abrogation of HSP70 expression in human oral cancer cells. Int. J. Cancer 2000; 85: 1-5.